Arak, H. and Kuş, T. 2024. Prognostic and Predictive Significance of HER2-low Expression in Metastatic Hormone Receptor Positive Breast Cancer Patients Receiving CDK4-6 Inhibitor Therapy. European Journal of Therapeutics. 30, 5 (May 2024), 662–674. DOI:https://doi.org/10.58600/eurjther2151.